AXGN Relative Valuation
AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AXGN is overvalued; if below, it's undervalued.
Historical Valuation
AxoGen Inc (AXGN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -17.31. The fair price of AxoGen Inc (AXGN) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：28.33
Fair
616.42
PE
1Y
3Y
5Y
Trailing
Forward
40.07
EV/EBITDA
AxoGen Inc. (AXGN) has a current EV/EBITDA of 40.07. The 5-year average EV/EBITDA is 21.66. The thresholds are as follows: Strongly Undervalued below -188.77, Undervalued between -188.77 and -83.55, Fairly Valued between 126.88 and -83.55, Overvalued between 126.88 and 232.09, and Strongly Overvalued above 232.09. The current Forward EV/EBITDA of 40.07 falls within the Historic Trend Line -Fairly Valued range.
158.89
EV/EBIT
AxoGen Inc. (AXGN) has a current EV/EBIT of 158.89. The 5-year average EV/EBIT is 49.57. The thresholds are as follows: Strongly Undervalued below -1655.04, Undervalued between -1655.04 and -802.74, Fairly Valued between 901.87 and -802.74, Overvalued between 901.87 and 1754.17, and Strongly Overvalued above 1754.17. The current Forward EV/EBIT of 158.89 falls within the Historic Trend Line -Fairly Valued range.
5.29
PS
AxoGen Inc. (AXGN) has a current PS of 5.29. The 5-year average PS is 3.16. The thresholds are as follows: Strongly Undervalued below 0.38, Undervalued between 0.38 and 1.77, Fairly Valued between 4.56 and 1.77, Overvalued between 4.56 and 5.95, and Strongly Overvalued above 5.95. The current Forward PS of 5.29 falls within the Overvalued range.
60.18
P/OCF
AxoGen Inc. (AXGN) has a current P/OCF of 60.18. The 5-year average P/OCF is 127.58. The thresholds are as follows: Strongly Undervalued below -4026.00, Undervalued between -4026.00 and -1949.21, Fairly Valued between 2204.38 and -1949.21, Overvalued between 2204.38 and 4281.17, and Strongly Overvalued above 4281.17. The current Forward P/OCF of 60.18 falls within the Historic Trend Line -Fairly Valued range.
79.19
P/FCF
AxoGen Inc. (AXGN) has a current P/FCF of 79.19. The 5-year average P/FCF is -3.07. The thresholds are as follows: Strongly Undervalued below -270.81, Undervalued between -270.81 and -136.94, Fairly Valued between 130.80 and -136.94, Overvalued between 130.80 and 264.67, and Strongly Overvalued above 264.67. The current Forward P/FCF of 79.19 falls within the Historic Trend Line -Fairly Valued range.
AxoGen Inc (AXGN) has a current Price-to-Book (P/B) ratio of 10.81. Compared to its 3-year average P/B ratio of 4.90 , the current P/B ratio is approximately 120.90% higher. Relative to its 5-year average P/B ratio of 4.93, the current P/B ratio is about 119.45% higher. AxoGen Inc (AXGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -4.68%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.82% , the current FCF yield is about -100.00% lower.
12.54
P/B
Median3y
4.90
Median5y
4.93
0.26
FCF Yield
Median3y
-4.68
Median5y
-5.82
Competitors Valuation Multiple
The average P/S ratio for AXGN's competitors is 0.00, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 23.51%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AXGN increased by 99.36% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -218.71 to -670.87.
The secondary factor is the Revenue Growth, contributed 23.51%to the performance.
Overall, the performance of AXGN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is AxoGen Inc (AXGN) currently overvalued or undervalued?
What is AxoGen Inc (AXGN) fair value?
How does AXGN's valuation metrics compare to the industry average?
What is the current P/B ratio for AxoGen Inc (AXGN) as of Dec 05 2025?
What is the current FCF Yield for AxoGen Inc (AXGN) as of Dec 05 2025?
What is the current Forward P/E ratio for AxoGen Inc (AXGN) as of Dec 05 2025?